MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies_Pain
Bright Minds Biosciences Inc. (NASDAQ: DRUG)
Organization & Developments: Bright Minds
Parents
Bright Minds Biosciences Inc. (NASDAQ: DRUG)
Children
*Bright Minds has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain.
*Bright Minds is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain.
2024: Bright Minds Biosciences: BMB-101's Phase 2 Trials Could Unlock Epilepsy Market Potential
2025: Bright Minds Biosciences: Looking To Change Scope Of Epilepsy Disorder Treatments With BMB-101
Jumps
Finance & Acquisitions: Bright Minds
Key People: Bright Minds